Skip to main content
. 2011 Nov 1;11:470. doi: 10.1186/1471-2407-11-470

Figure 10.

Figure 10

Comparison between different treatment methodologies in PC3-TR cells. (a) Mitoxantrone (b) and mithramycin in PC3-TR prostate cancer cells. Single-agent treatments are shown as "dark grey diamonds", sequential combination treatments with 10 ng/mL of TRAIL are shown as "light grey squares" and simultaneous combination treatments with 10 ng/mL of TRAIL are shown as "grey triangles". Data are presented on a logarithmic scale and the lines connecting data points are for visualization only.